Published in Liver Int on January 04, 2012
Living-donor liver transplantation and hepatitis C. HPB Surg (2013) 0.90
Management of hepatitis C infection before and after liver transplantation. World J Gastroenterol (2015) 0.85
How important is donor age in liver transplantation? World J Gastroenterol (2016) 0.83
Liver transplantation and hepatitis C. Int J Hepatol (2012) 0.79
Immunological dysfunction during or after antiviral therapy for recurrent hepatitis C reduces graft survival. Hepatol Int (2013) 0.76
[One thousand liver transplants. Hospital Clinic i Provincial de Barcelona (Spain)]. Cir Esp (2005) 1.39
Liver transplantation for malignant diseases: selection and pattern of recurrence. World J Surg (2001) 0.98
A personalized preclinical model to evaluate the metastatic potential of patient-derived colon cancer initiating cells. Clin Cancer Res (2013) 0.94
Successful transplantation of organs from a donor with postneurosurgical meningitis caused by Escherichia coli. Transplantation (2012) 0.90
Single HCC in cirrhotic patients: liver resection or liver transplantation? Long-term outcome according to an intention-to-treat basis. Ann Surg Oncol (2012) 0.88
Outcome of patients following hepatic resection for metastatic cutaneous and ocular melanoma. J Hepatobiliary Pancreat Sci (2011) 0.87
Evolution and management of de novo neoplasm post-liver transplantation: a 20-year experience from a single European centre. Hepatol Int (2010) 0.86
Optimization of liver transplantation as a treatment of intrahepatic hepatocellular carcinoma recurrence after partial liver resection: experience of a single European series. World J Surg (2010) 0.84
Liver transplantation in hepatocellular carcinoma. Transpl Int (2005) 0.81
Transjugular intrahepatic portosystemic shunt for the treatment of sinusoidal obstruction syndrome in a liver transplant recipient and review of the literature. Liver Transpl (2012) 0.81
Visceral leishmaniasis among liver transplant recipients: an overview. Liver Transpl (2008) 0.79
Prognostic factors and time-related changes influence results of colorectal liver metastases surgical treatment: a single-center analysis. World J Gastroenterol (2009) 0.78
Optimization of liver grafts in liver retransplantation: a European single-center experience. Surgery (2008) 0.77
Long-term outcome of hepatitis C virus infections acquired after pediatric liver transplantation. Liver Transpl (2011) 0.77
Impact of prior portosystemic shunt procedures on outcome of liver transplantation. Surgery (2005) 0.77
[Krukenberg's tumor as the first clinical manifestation of fibrolamellar hepatocarcinoma]. Gastroenterol Hepatol (2008) 0.76
Twelve-week posttreatment follow-up to predict sustained virologic response for recurrent hepatitis C infection in liver recipients. Transplantation (2012) 0.76
[Controlled, open, parallel-group study of the clinical and microbiological efficacy of piperacillin-tazobactam versus metronidazole + gentamicin in urgent colorectal surgery]. Cir Esp (2006) 0.76
Does pre-liver transplant HBV DNA level affect HBV recurrence or survival in liver transplant recipients receiving HBIg and nucleos(t)ide analogues? Ann Hepatol (2011) 0.75
Low plasma levels of antithrombin III in the early post-operative period following pediatric liver transplantation: should they be replaced? A single-center pilot study. Pediatr Transplant (2014) 0.75
[Biliary adenocarcinoma arising from atypical benign lesions]. Cir Esp (2005) 0.75
[Therapeutic management of juxtapapillary duodenal diverticulum]. Cir Esp (2012) 0.75